(Q44565138)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24549921%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Etanercept therapy in Behçet's disease. The tight control strategy in refractory disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24549921%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24549921%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

R H A Mohammed

series ordinal

1

1 reference

4 December 2017

1 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24549921%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

number of pages

7

1 reference

Zeitschrift fuer Rheumatologie

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24549921%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24549921%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24549921%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

650-656

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24549921%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00393-013-1307-6

8 March 2020

exact match

0 references

cites work

Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report

1 reference

https://api.crossref.org/works/10.1007%2FS00393-013-1307-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00393-013-1307-6

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00393-013-1307-6

Treatment of Behçet's disease--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00393-013-1307-6

Behçet's disease: a new target for anti-tumour necrosis factor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00393-013-1307-6

Remission of Behçet's syndrome with tumour necrosis factor alpha blocking therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00393-013-1307-6

Biologics in the treatment of uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00393-013-1307-6

Close association of HLA-Bw51 with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00393-013-1307-6

Clinical experience with adalimumab in the treatment of ocular Behçet disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00393-013-1307-6

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00393-013-1307-6

Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00393-013-1307-6

Safety and efficacy of infliximab therapy in active behcet's uveitis: an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00393-013-1307-6

Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet's disease (BD) in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00393-013-1307-6

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

21 January 2018

1 reference

12 December 2020

Role of gammadelta T lymphocytes in the development of Behçet's disease

1 reference

12 December 2020

Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.

1 reference

12 December 2020

IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells

1 reference

12 December 2020

Efficacy of infliximab on the acute attack of uveitis

1 reference

12 December 2020

Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

1 reference

12 December 2020

Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity

1 reference

12 December 2020

Cytokine profile in Behçet's disease patients. Relationship with disease activity

1 reference

12 December 2020

Immunopathological aspects of Behçet's disease

1 reference

12 December 2020

IL-8 producing cells in patients with Behçet's disease

1 reference

12 December 2020

Behçet's disease: an update on the pathogenesis

1 reference

12 December 2020

10.1007/S00393-013-1307-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24549921%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference